IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection.
about
Cell death programs in Yersinia immunity and pathogenesisBurkholderia cepacia Complex Vaccines: Where Do We Go from here?Omics strategies for revealing Yersinia pestis virulenceIn vivo transcriptional profiling of Yersinia pestis reveals a novel bacterial mediator of pulmonary inflammationDeletion of Braun lipoprotein and plasminogen-activating protease-encoding genes attenuates Yersinia pestis in mouse models of bubonic and pneumonic plague.Aspergillus and Fusarium corneal infections are regulated by Th17 cells and IL-17-producing neutrophils.TNFα and IFNγ but not perforin are critical for CD8 T cell-mediated protection against pulmonary Yersinia pestis infection.An encapsulated Yersinia pseudotuberculosis is a highly efficient vaccine against pneumonic plagueLcrV delivered via type III secretion system of live attenuated Yersinia pseudotuberculosis enhances immunogenicity against pneumonic plague.A ΔclpB mutant of Francisella tularensis subspecies holarctica strain, FSC200, is a more effective live vaccine than F. tularensis LVS in a mouse respiratory challenge model of tularemia.Yersinia pestis YopE contains a dominant CD8 T cell epitope that confers protection in a mouse model of pneumonic plagueAdvanced Development of the rF1V and rBV A/B Vaccines: Progress and Challenges.High-throughput, signature-tagged mutagenic approach to identify novel virulence factors of Yersinia pestis CO92 in a mouse model of infection.Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination.Vaccine-induced th17 cells are maintained long-term postvaccination as a distinct and phenotypically stable memory subset.Induction of pulmonary mucosal immune responses with a protein vaccine targeted to the DEC-205/CD205 receptorIntramuscular Immunization of Mice with a Live-Attenuated Triple Mutant of Yersinia pestis CO92 Induces Robust Humoral and Cell-Mediated Immunity To Completely Protect Animals against Pneumonic Plague.Oral administration of a recombinant attenuated Yersinia pseudotuberculosis strain elicits protective immunity against plagueIFN-γ induction by neutrophil-derived IL-17A homodimer augments pulmonary antibacterial defense.Intranasal prophylaxis with CpG oligodeoxynucleotide can protect against Yersinia pestis infection.Immunity to infection in IL-17-deficient mice and humansA Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates.Protective Immunity Elicited by Oral Immunization of Mice with Salmonella enterica Serovar Typhimurium Braun Lipoprotein (Lpp) and Acetyltransferase (MsbB) Mutants.Th17 cell based vaccines in mucosal immunity.Plague vaccines: current developments and future perspectives.Immunology of Yersinia pestis Infection.Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.Multiple antigen peptide containing B and T cell epitopes of F1 antigen of Yersinia pestis showed enhanced Th1 immune response in murine model.Identification of New Virulence Factors and Vaccine Candidates for Yersinia pestis.Immunisation of two rodent species with new live-attenuated mutants of Yersinia pestis CO92 induces protective long-term humoral- and cell-mediated immunity against pneumonic plague.Single vector platform vaccine protects against lethal respiratory challenge with Tier 1 select agents of anthrax, plague, and tularemia.
P2860
Q21131303-1D547195-761C-4E85-BC92-51905AC47205Q26752346-4D381E52-2740-4713-93B4-22F56CED5B1AQ28710346-0E9A1C56-D269-42EF-AA05-3ECF3A8A175DQ30371862-83CF9A7E-82CE-4E59-8D0C-0F8A5D272606Q33603015-B49AD602-AE12-4F9F-AB58-867FB31BCCE0Q33607420-E4782DF5-F5B9-42AA-A623-CC4ACCE94497Q33650538-8787AA47-2269-4031-A0DB-0882DA606538Q34163944-E5560BCB-A306-462B-BBBA-C11AEE2950A9Q34298699-A6B6F0C2-A70C-4B7B-990C-ECE180B09CB9Q35043536-9351E16B-5F3B-4309-B3DF-691A05FFF111Q35091255-5866B3CA-187E-49B5-95BE-9130D335CCA4Q35418294-481D3C8A-F8A2-44F3-9796-97501F99170FQ35439470-128DBC5B-FC43-48EB-905D-3DB1162C1546Q35810279-4480526C-094A-4BD1-9713-C637FBBF8880Q36277359-60F0D346-94B0-40EE-892D-0AED928EAFC8Q36288336-435DD48D-9337-4827-9C95-07BF093B2D2BQ36316792-5EFC93F0-F2B2-4364-812C-78777CAF5ED1Q36372952-AA7858D2-EBA8-4337-BE4A-081289161D64Q36669812-223DF89D-CB61-4703-987E-0BF0E72A79CEQ36911486-2D755037-D1DF-44A6-BEDC-1DBB826E7C04Q37037708-B1745B18-9246-4AE2-A865-49FF9356C032Q37067254-CCC6651A-66E0-414B-B4F4-01AE2CED0FAEQ37405767-6303F6A6-CC54-4D4F-8D64-AF742BEB4C0BQ38106558-6E3A4ECC-757D-4A96-B7B8-01BDD0D39354Q38514208-CE2464D6-69D8-494F-ADDB-EB2C0547E7DFQ40512106-D8F9FA3E-243D-47B3-9C93-5077AA691E06Q40557637-0E41CA60-9AA7-4A94-B6CC-5FAA332AEDC0Q41400297-E5CE7C81-4175-4A32-80E6-70B4E7CB528DQ46463260-36B9F3A2-C752-483E-B6BF-F76E8230A289Q47293934-3E2D5A99-3BA9-4695-968E-982E8C688938Q55361721-3432F86A-79AE-421C-8388-F1441FD7D453
P2860
IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection.
@ast
IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection.
@en
IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection.
@nl
type
label
IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection.
@ast
IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection.
@en
IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection.
@nl
prefLabel
IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection.
@ast
IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection.
@en
IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection.
@nl
P2093
P2860
P356
P1476
IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection.
@en
P2093
Frank M Szaba
Jr-Shiuan Lin
Lawrence W Kummer
Stephen T Smiley
P2860
P304
P356
10.4049/JIMMUNOL.1003303
P407
P577
2010-12-20T00:00:00Z